iShares U.S. Pharmaceuticals ETFiShares U.S. Pharmaceuticals ETFiShares U.S. Pharmaceuticals ETF

iShares U.S. Pharmaceuticals ETF

No trades
See on Supercharts

Key stats


Assets under management (AUM)
‪576.64 M‬USD
Fund flows (1Y)
‪−100.26 M‬USD
Dividend yield (indicated)
1.64%
Discount/Premium to NAV
0.02%
Shares outstanding
‪8.15 M‬
Expense ratio
0.38%

About iShares U.S. Pharmaceuticals ETF


Brand
iShares
Home page
Inception date
May 1, 2006
Structure
Open-Ended Fund
Index tracked
DJ US Select / Pharmaceutical
Replication method
Physical
Management style
Passive
Dividend treatment
Distributes
Distribution tax treatment
Qualified dividends
Income tax type
Capital Gains
Max ST capital gains rate
39.60%
Max LT capital gains rate
20.00%
Primary advisor
BlackRock Fund Advisors
Distributor
BlackRock Investments LLC
ISIN
US4642888360
IHE tracks a broad index of US pharmaceutical companies. The fund provides exposure to the manufacturers of prescription or over-the-counter drugs, such as aspirin, cold remedies and birth control pills. The index also includes vaccine producers. IHE may also include companies of all sizes, ranging from large- to small-cap. The index weights its constituents by market cap, with a cap of up to 22.5% per individual company and is rebalanced quarterly. IHE uses a sampling strategy that involves investing in a representative sample of securities that collectively has an investment profile similar to that of an applicable underlying index. Index components are selected on an annual basis.

Broaden your horizons with more funds linked to IHE via country, focus, and more.

Classification


Asset Class
Equity
Category
Sector
Focus
Health care
Niche
Pharmaceuticals
Strategy
Vanilla
Geography
U.S.
Weighting scheme
Market cap
Selection criteria
Market cap
What's in the fund
Exposure type
StocksBonds, Cash & Other
Health Technology
Stock breakdown by region
94%5%0.5%
Top 10 holdings
Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


An exchange-traded fund (ETF) is a collection of assets (stocks, bonds, commodities, etc.) that track an underlying index and can be bought on an exchange like individual stocks.
IHE trades at 71.36 USD today, its price has risen 0.28% in the past 24 hours. Track more dynamics on IHE price chart.
IHE net asset value is 71.14 today — it's risen 5.12% over the past month. NAV represents the total value of the fund's assets less liabilities and serves as a gauge of the fund's performance.
IHE assets under management is ‪576.64 M‬ USD. AUM is an important metric as it reflects the fund's size and can serve as a gauge of how successful the fund is in attracting investors, which, in its turn, can influence decision-making.
IHE price has risen by 8.73% over the last month, and its yearly performance shows a −1.34% decrease. See more dynamics on IHE price chart.
NAV returns, another gauge of an ETF dynamics, showed a 9.76% increase in three-month performance and has increased by 0.33% in a year.
IHE fund flows account for ‪−100.26 M‬ USD (1 year). Many traders use this metric to get insight into investors' sentiment and evaluate whether it's time to buy or sell the fund.
Since ETFs work like an individual stock, they can be bought and sold on exchanges (e.g. NASDAQ, NYSE, EURONEXT). As it happens with stocks, you need to select a brokerage to access trading. Explore our list of available brokers to find the one to help execute your strategies. Don't forget to do your research before getting to trading. Explore ETFs metrics in our ETF screener to find a reliable opportunity.
IHE invests in stocks. See more details in our Analysis section.
IHE expense ratio is 0.38%. It's an important metric for helping traders understand the fund's operating costs relative to assets and how expensive it would be to hold the fund.
No, IHE isn't leveraged, meaning it doesn't use borrowings or financial derivatives to magnify the performance of the underlying assets or index it follows.
In some ways, ETFs are safe investments, but in a broader sense, they're not safer than any other asset, so it's crucial to analyze a fund before investing. But if your research gives a vague answer, you can always refer to technical analysis.
Today, IHE technical analysis shows the strong buy rating and its 1-week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1-month rating IHE shows the strong buy signal. See more of IHE technicals for a more comprehensive analysis.
Yes, IHE pays dividends to its holders with the dividend yield of 1.64%.
IHE trades at a premium (0.02%).
Premium/discount to NAV expresses the difference between the ETF’s price and its NAV value. A positive percentage indicates a premium, meaning the ETF trades at a higher price than the calculated NAV. Conversely, a negative percentage indicates a discount, suggesting the ETF trades at a lower price than NAV.
IHE shares are issued by BlackRock, Inc.
IHE follows the DJ US Select / Pharmaceutical. ETFs usually track some benchmark seeking to replicate its performance and guide asset selection and objectives.
The fund started trading on May 1, 2006.
The fund's management style is passive, meaning it's aiming to replicate the performance of the underlying index by holding assets in the same proportions as the index. The goal is to match the index's returns.